Biogen files reply, supports dismissing product-hopping claims in US case
MLex Summary: Biogen filed a reply in support of its motion to dismiss amended claims accusing it of using a “market switch” to unlawfully impair competition from generic versions of its brand-name...To view the full article, register now.
Already a subscriber? Click here to view full article